I this imaging modality.
14 Radiography is effective in visualizing calcification of some tumor types and/or secondary skeletal changes. For example, a dumbbell-shaped neurofibroma that involves proximal spinal nerves will often deform the adjacent bone structures of the spine, for example, causing an enlarged neural foramen and scalloping of the vertebral body.
Computed Tomography
Although MR imaging has mostly replaced CT in the evaluation of patients with peripheral nerve tumors, CT is still useful in 1) evaluating patients who are not MR compatible, like those with internal metallic devices such as pacemakers; 2) studying secondary changes in skeletal structures associated with mass lesions, particularly in the spine and chest areas; 3) detecting and characterizing calcification in tumors; and 4) evaluating the chest and abdomen for signs of metastasis of peripheral nerve tumors. 24 When CT scanning is advised, it is usually used with the addition of a contrast agent.
Ultrasonography
Ultrasonography is among the most widely available and least time-consuming imaging techniques available for the examination of suspected nerve masses. Ultrasonography is safe and causes minimal patient discomfort. The operator can scan long segments of nerves longitudinally, in real time, which would be very time consuming and expensive with MR imaging. Ultrasonography can be particularly useful intraoperatively for localizing tumors that are difficult to see and searching for residual tumors or cystic structures after resection. It is also useful in distinguishing cystic from solid tumors and in visualizing the relationship of major blood vessels to masses. 17 Similar to MR imaging, ultrasonography may be used to visualize the patterns associated with various tumor types. 1, 19, 23 For example, neurofibromas tend to enhance heterogeneously on ultrasonography and have a higher echogenicity in the center than on the periphery. This pattern on imaging, also called the target sign, has been correlated with the benign nature of a tumor. 2 
Positron Emission Tomography
Positron emission tomography is the tool of choice when it comes to observing metabolic changes. This modality uses radioisotopes, such as fluorodeoxyglucose, to visualize sites of glucose metabolism. Malignant tumors tend to have a higher metabolic rate than benign tumors. This property is used in PET scanning to locate potentially malignant masses in peripheral nerves and direct biopsy sampling to the hyperactive areas of a tumor. 12 
Magnetic Resonance Imaging
Magnetic resonance imaging is usually the modality of choice in preoperative evaluation of peripheral nerve tumors and other types of masses. It provides exceptional contrast of soft-tissue structures, high spatial resolution, multiplanar imaging capability, and no known risks or side effects to patients. When used together with a clinical examination, MR imaging can confirm the presence of a mass and visualize the fine anatomical details of involved peripheral nerves. Magnetic resonance neurography 8, 9, 15 comprises a series of techniques that further enhance the contrast between peripheral nerves and surrounding tissues. By employing special pulse sequences, high-field strength scanners, and multiple phased-array coils optimized for a particular body region, an improved signal-tonoise ratio can be achieved, leading to a higher spatial resolution and greater contrast while maintaining an adequate FOV (Fig. 1 ). This improved contrast and resolution helps greatly in determining the precise location, size, shape, and resectability of peripheral nerve masses (Figs. 2-6 ). Additionally, 3D reconstruction algorithms are useful in helping the clinician to visualize the tumor's entire extent and geometry. For example, MR neurography makes it possible to distinguish the more homogeneous appearance of tumors and cysts from the characteristic fascicular structure of normal nerves (Fig. 2) .
Peripheral nerve masses are generally visualized in two or more orthogonal planes to obtain a longitudinal and a cross-sectional view of the nerve and/or the tumor. Although an in-plane longitudinal view offers a better perspective on the span of the tumor, the cross-sectional plane displays the size and relationship of the tumor to the fascicles of the affected nerve (Figs. 3 and 4) . Combining images from these two planes gives an idea of the tumor shape. The choice of exact image orientation usually depends on the anatomical region under examination. For masses in the extremities and spine, axial T1-and T2-weighted images are common; coronal and oblique sagittal planes are typically used for visualizing brachial plexus structures.
Despite the availability of many different MR imaging pulse sequences, most peripheral nerve tumors are evaluated using a combination of a few T1-and T2-weighted pulse sequences. Because the fat present in the thin layer of perineurium and internal epineurial tissue appears bright, T1-weighted images (short TR and TE) show finer anatomical details, such as the fascicular structures of nerves. The images appear isointense to the neighboring normal muscle tissues. When used in combination with contrast agents like Gd, T1-weighted images can accentuate the boundaries between tumor tissue and nerve fascicles ( Fig. 3 ) and are also useful in distinguishing between solid, cystic, and necrotic areas of tumors.
Pathological changes in nerves and mass lesions are best shown on T2-weighted (long TR and TE) images (Fig. 1) . In T2-weighted images, normal peripheral nerves appear isointense to slightly hyperintense relative to normal muscle. Additionally, fat-suppressed FSE or STIR techniques demonstrate increased sensitivity to free water content and are useful in highlighting even subtle tissue abnormalities caused by tumors. By suppressing the hyperintense fat signal, lesion to background contrast is enhanced, making it easier to locate peripheral nerve tumors (Fig. 4) .
The exact choice of a specific pulse sequence is based on the balancing of factors such as scan time, spatial resolution, contrast, motion artifacts, and signal-to-noise ratio. Conventionally, standard T1 and T2 FSE images are obtained in all cases and are often enough to evaluate peripheral nerve masses. Other imaging techniques like the STIR sequence and T2 FSE with frequency-selective fat saturation provide suppression of signal from fat tissue, thus increasing the conspicuity of nonfat tissues such as mass lesions. However, they suffer from lower signal-tonoise ratio and uneven fat suppression across the FOV, respectively. types, T1-and T2-weighted images are obtained exactly at the same location and plane using the same FOV. This allows the radiologist to match the fine anatomical nerve features seen on T1-weighted images with the pathological tissue features seen on T2-weighted images. 22 Most peripheral nerve sheath tumors appear isointense or slightly hyperintense on T1-weighted images and hyperintense on T2-weighted images relative to the signal intensity of neighboring normal muscle tissue (Figs. 3-5) . Although it is possible to visualize the nerve fascicles in relationship to intra-and extraneural tumors, as well as to create a 3D representation of the tumor, determination of the exact tumor type or its origin is still usually difficult, if not impossible, based solely on imaging data. Certain peripheral nerve masses do present unique characteristics. 18, 26 The majority of tumors show enhancement following administration of contrast agents like Gd (Figs. 3  and 4) . Two-thirds of neurofibromas display increased central and decreased peripheral signal intensity on T1-weighted images (the "target sign") and an opposite pattern of increased peripheral and decreased central signal intensity on T2-weighted images. 21, 27 Additionally, hyper- plastic lymph nodes may resemble tumors and enhance similarly, making it difficult to distinguish them from each other. In contrast, ganglion cysts, 28 which do not enhance, appear unusually hypointense on T1-weighted images, and hyperintense on T2-weighted images and can thus be distinguished from solid masses (Fig. 2) . 28 Despite many advances in technology and technique, MR imaging is still limited in its ability to identify aspects of tumor pathology such as tumor grade or malignancy accurately. 5, 18, 26, 27 Picking up small changes in size or volume of mass lesions is also difficult on MR imaging. In addition, the appearance and intensity of images obtained with MR imaging may change from one patient to another and between multiple runs on the same patient. Magnetic resonance imaging can also suffer from motion artifacts, uneven fat suppression, and poor signal-to-noise ratio. Therefore, evaluation of differences in image intensity can be difficult to interpret. Sometimes it is useful to make semiquantitative determinations by using a ratio of signal intensity in the suspected pathological areas to that of the adjacent normal tissues. Software algorithms can also help in synchronizing the T1-and T2-weighted images and in determining the approximate size of the mass.
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CLINICAL APPLICATION
The evaluation of a peripheral nerve tumor usually entails a multipronged approach, with patient complaints, clinical findings, electrodiagnostic test results, and imaging studies all playing a critical role. Imaging data obtained and analyzed at different points during a patient's clinical course provide important information on the location, size, shape, rate of growth, and resectability of a mass that helps in determining the proper course of treatment. phy) is used to visualize the relationship of a tumor to the neighboring tissues. Preoperative imaging studies can pinpoint the location and size of the tumor, determine the intraneural or extraneural nature of the tumor, visualize its relationship to peripheral nerve fascicles to assess the chances of resecting the tumor without disturbing function, and determine the best surgical approach (Figs. 3-5) .
Magnetic resonance imaging is also useful in delineating the relationship of a peripheral nerve tumor to other adjacent structures such as major blood vessels and inter- nal organs. For example, MR imaging of the pelvis can be used to appreciate whether or not a peripheral nerve mass is impinging on the ureter of the kidney. Displacement or encasement of the ureter and, if present, hydronephrosis can be seen in the images. If involvement of the ureter is suspected, then preoperative stenting can be performed to minimize the risk of surgically lacerating the ureter during tumor dissection and resection. Magnetic resonance imaging can also be used to demonstrate the relationship of an extraneural mass to important adjacent peripheral nerves and vascular structures (Fig. 6) .
Malignant peripheral nerve tumors are rare and hard to distinguish from benign nerve masses preoperatively on the basis of clinical symptoms and imaging characteristics. 5 Definitive diagnosis of a malignancy is only achievable through the pathological analysis of a tumor biopsy specimen. However, certain features suggest malignancy but do not prove it, including evidence of metastasis, rapid growth, size greater than 5 cm, increased metabolic activity on a PET scan, and a history of having malignant peripheral nerve tumor(s) (Fig. 7) . In contrast, many benign peripheral nerve tumors either reach a point where they stop growing or grow very slowly. Rarely, such tumors also regress. Serial imaging studies thus provide important information on the pathological grade and growth course of a tumor (Fig. 8) .
Magnetic resonance imaging can also help to distinguish between recurrent tumor and radiation-induced plexitis or neuritis. Although recurrent tumors usually present on imaging with hyperintense T2-weighted signal and focal and irregular enlargement of the associated nerve(s), radiation-induced plexitis or neuritis appears as uniform enlargement or narrowing of the involved nerve(s) with a diffuse pattern of increased T2 signal (Fig. 9) .
Intraoperative ultrasonography can aid in locating and resecting mass lesions in cases of multinodular or multiple tumors, as well as in distinguishing tumors from functioning and/or normal-appearing nerve fascicles. 25 Ultrasonography has also been used to guide the percutaneous biopsy of a tumor suspected of being malignant. However, we do not advocate such an approach, favoring instead open biopsy and resection of a tumor to avoid damaging functioning nerve fibers (which can cause significant pain, as well as weakness and numbness).
Neurosurg
Postoperatively, imaging is used to determine the extent of resection performed to verify if it was total or partial. Subsequent follow-up imaging helps in identifying growth of residual tumor, as well as determining if there is tumor recurrence, particularly if there are new clinical symptoms and findings (Fig. 10) .
CONCLUSIONS
Although imaging alone might not be sufficient to provide an accurate diagnosis of a peripheral nerve mass, it plays a critical role. Among all imaging methods, MR imaging is the preferred modality for evaluating peripheral nerve tumors and other lesion types. In some cases, the appearance of a mass can be unique enough to provide a strong presumptive diagnosis. However, imaging cannot reliably determine the pathological type of a tumor and thus cannot differentiate between benign and malignant masses or distinguish one type of tumor from another. Nevertheless, imaging can provide a very useful roadmap to the physician evaluating peripheral nerve lesions and can assist in navigating a safe and effective clinical course.
